Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Outcomes of Hyper-CVAD Treatment in Lymphoblastic Lymphoma

NCT01813344 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT01813344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01813344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Outcomes of Hyper-CVAD Treatment in Lymphoblastic Lymphoma
Lead sponsor
Ajou University School of Medicine
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
Not reported
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic lymphoma